Intensive serum urate lowering with oral urate ‐lowering therapy for erosive gout: A randomized double‐blind controlled trial

ConclusionCompared with a serum urate target below 0.30mmol/L, more intensive serum urate-lowering is difficult to achieve with oral ULT, leads to high medication burden, and does not improve bone erosion scores in erosive gout.

Source: Arthritis and Rheumatology - December 20, 2021 Category: Rheumatology Authors: Nicola Dalbeth, Anthony J Doyle, Karen Billington, Greg D Gamble, Paul Tan, Kieran Latto, Thrishila Parshu Ram, Ravi Narang, Rachel Murdoch, David Bursill, Borislav Mihov, Lisa K Stamp, Anne Horne Tags: Full Length Source Type: research